# RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION

> **NCT05320328** · — · UNKNOWN · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 50 (estimated)

## Conditions studied

- Bile Duct Neoplasms
- Gall Bladder Carcinoma

## Interventions

- **DEVICE:** Radio frequency ablation

## Key facts

- **NCT ID:** NCT05320328
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-10
- **Primary completion:** 2022-06-10
- **Final completion:** 2022-12-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05320328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05320328, "RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05320328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*